Intellectual Property Magazine
US passes bills to update Orange and Purple books
Catherine White
The US House of Representatives has unanimously passed twobills that will make amendments to the US Food and Drug Administration’s
(FDA)Orange Book that provides information on generic drugs and its Purple Book, forbiosimilars.